139 related articles for article (PubMed ID: 30377992)
1. Patient and Physician Preferences for Therapy Characteristics for Psoriasis: A Discrete Choice Experiment in Japan.
Bolt T; Kobayashi H; Mahlich J
Pharmacoecon Open; 2019 Jun; 3(2):255-264. PubMed ID: 30377992
[TBL] [Abstract][Full Text] [Related]
2. Relative Importance of Mode of Administration in Treatment Preferences among Plaque Psoriasis Patients in the United States.
Feldman SR; Holmen Moeller A; Erntoft Idemyr ST; González JM
J Health Econ Outcomes Res; 2017; 4(2):141-157. PubMed ID: 37661952
[No Abstract] [Full Text] [Related]
3. The importance of understanding patient and physician preferences for psoriasis treatment characteristics: a systematic review of discrete-choice experiments.
Sain N; Willems D; Charokopou M; Hiligsmann M
Curr Med Res Opin; 2020 Aug; 36(8):1257-1275. PubMed ID: 32468865
[No Abstract] [Full Text] [Related]
4. A discrete choice experiment on oral and injection treatment preferences among moderate-to-severe psoriasis patients in Japan.
Komine M; Kim H; Yi J; Zhong Y; Sakai Y; Crawford B; Habiro K; Hikichi Y; Feldman SR
J Dermatol; 2023 Jun; 50(6):766-777. PubMed ID: 36808765
[TBL] [Abstract][Full Text] [Related]
5. Hematologists' Preferences for First-line Therapy Characteristics for Multiple Myeloma in Japan: Attribute Rating and Discrete Choice Experiment.
Bolt T; Mahlich J; Nakamura Y; Nakayama M
Clin Ther; 2018 Feb; 40(2):296-308.e2. PubMed ID: 29358004
[TBL] [Abstract][Full Text] [Related]
6. Dermatologist and Patient Preferences in Choosing Treatments for Moderate to Severe Psoriasis.
Alcusky M; Lee S; Lau G; Chiu GR; Hadker N; Deshpande A; Fleming S; Vance N; Fakharzadeh S
Dermatol Ther (Heidelb); 2017 Dec; 7(4):463-483. PubMed ID: 29052800
[TBL] [Abstract][Full Text] [Related]
7. Physician Preferences and Shared-Decision Making for the Traditional Chinese Medicine Treatment of Lung Cancer: A Discrete-Choice Experiment Study in China.
Yan J; Wei Y; Teng Y; Liu S; Li F; Bao S; Ren Y; Chen Y
Patient Prefer Adherence; 2022; 16():1487-1497. PubMed ID: 35747587
[TBL] [Abstract][Full Text] [Related]
8. Patient and physician preferences for atopic dermatitis injection treatments in Japan.
Okubo Y; Ho KA; Fifer S; Fujita H; Oki Y; Taguchi Y
J Dermatolog Treat; 2020 Dec; 31(8):821-830. PubMed ID: 31250681
[No Abstract] [Full Text] [Related]
9. Patients' and Physicians' Preferences for Systemic Psoriasis Treatments: A Nationwide Comparative Discrete Choice Experiment (PsoCompare).
Schaarschmidt ML; Herr R; Gutknecht M; Wroblewska K; Gerdes S; Sticherling M; Augustin M; Peitsch WK
Acta Derm Venereol; 2018 Feb; 98(2):200-205. PubMed ID: 29110022
[TBL] [Abstract][Full Text] [Related]
10. Patient preference for biologic treatments of psoriasis in Japan.
Tada Y; Ishii K; Kimura J; Hanada K; Kawaguchi I
J Dermatol; 2019 Jun; 46(6):466-477. PubMed ID: 30985030
[TBL] [Abstract][Full Text] [Related]
11. Valuing injection frequency and other attributes of type 2 diabetes treatments in Australia: a discrete choice experiment.
Fifer S; Rose J; Hamrosi KK; Swain D
BMC Health Serv Res; 2018 Aug; 18(1):675. PubMed ID: 30165844
[TBL] [Abstract][Full Text] [Related]
12. Impact of clinical and demographic characteristics on patient preferences for psoriasis treatment features: Results from a discrete-choice experiment in a multicountry study.
Boeri M; Saure D; Schuster C; Hill J; Guerreiro M; Klein K; Hauber B
J Dermatolog Treat; 2022 May; 33(3):1598-1605. PubMed ID: 33406942
[TBL] [Abstract][Full Text] [Related]
13. Patient preferences for topical psoriasis treatments: a discrete choice experiment.
Hoelker S; Ninosu N; Buettner S; Peitsch WK; Schaarschmidt ML
J Dermatolog Treat; 2022 Aug; 33(5):2595-2604. PubMed ID: 35373695
[TBL] [Abstract][Full Text] [Related]
14. Patient-reported outcomes are important elements of psoriasis treatment decision making: A discrete choice experiment survey of dermatologists in the United States.
Feldman SR; Regnier SA; Chirilov A; Hey F; Gilloteau I; Cella D
J Am Acad Dermatol; 2019 Jun; 80(6):1650-1657. PubMed ID: 30703461
[TBL] [Abstract][Full Text] [Related]
15. Quantifying Physician Preferences for Systemic Atopic Dermatitis Treatments Using a Discrete-Choice Experiment.
Carrascosa Carrillo JM; Baselga Torres E; Gilaberte Calzada Y; Jurgens Martínez YN; Roustan Gullón G; Yanguas Bayona JI; Gómez Castro S; Ferrario MG; Rebollo Laserna FJ
Dermatol Ther (Heidelb); 2022 May; 12(5):1197-1210. PubMed ID: 35445962
[TBL] [Abstract][Full Text] [Related]
16. A discrete-choice experiment to quantify patient preferences for frequency of glucagon-like peptide-1 receptor agonist injections in the treatment of type 2 diabetes.
Hauber AB; Nguyen H; Posner J; Kalsekar I; Ruggles J
Curr Med Res Opin; 2016; 32(2):251-62. PubMed ID: 26549576
[TBL] [Abstract][Full Text] [Related]
17. Evaluating the concordance of physician judgments and patient preferences on AIDS/HIV therapy - a Discrete Choice Experiment.
Mühlbacher AC; Stoll M; Mahlich J; Nübling M
Health Econ Rev; 2013 Dec; 3(1):30. PubMed ID: 24351422
[TBL] [Abstract][Full Text] [Related]
18. Psoriasis patient preferences for the use of biologics during the coronavirus era.
Tada Y; Itakura A; Hosono K; Kawamura T
J Dermatol; 2023 May; 50(5):596-607. PubMed ID: 36628542
[TBL] [Abstract][Full Text] [Related]
19. Comparing preferences for outcomes of psoriasis treatments among patients and dermatologists in the U.K.: results from a discrete-choice experiment.
Gonzalez JM; Johnson FR; McAteer H; Posner J; Mughal F
Br J Dermatol; 2017 Mar; 176(3):777-785. PubMed ID: 27292093
[TBL] [Abstract][Full Text] [Related]
20. Patient preferences for psoriasis treatments: process characteristics can outweigh outcome attributes.
Schaarschmidt ML; Schmieder A; Umar N; Terris D; Goebeler M; Goerdt S; Peitsch WK
Arch Dermatol; 2011 Nov; 147(11):1285-94. PubMed ID: 22106115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
